The regulator said on Thursday it found no clinical need for outsourcing facilities to compound semaglutide, the active ingredient of Novos Wegovy and Ozempic, and tirzepatide, sold as Zepbound and Mounjaro by Lilly, from bulk drug substances
Gmez-Donoso C, Snchez-Villegas A, Martnez-Gonzlez MA, Gea A, Mendona RD, et al
Practical protocols for using each peptide Effective use requires understanding proper dosing, titration schedules, injection technique, monitoring, and adjustment strategies
Understanding Urine Tests: What Do These Tests Look For
Additional Phase 3 readouts across the TRIUMPH and TRANSCEND-T2D programs are expected through 2026 and 2027
Vernet P, Rigaudiere N, Ghyselinck N, Dufaure JP, Drevet JR